Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Nooka
Charise Gleason
Sagar Lonial

Current hematologic malignancy reports

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar Lonial
Current Hematologic Malignancy Reports|February 18, 2011
Is subcutaneous bortezomib ready for prime time?Sagar Lonial
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Current Hematologic Malignancy Reports|May 8, 2010
Improving induction therapy in multiple myelomaAjay Nooka, Charise Gleason, Sagar Lonial
Current Hematologic Malignancy Reports|April 29, 2010
Treatment of relapsed and refractory myelomaJonathan Kaufman, Charise Gleason, Sagar Lonial
Current Hematologic Malignancy Reports|February 18, 2011
Is subcutaneous bortezomib ready for prime time?Sagar Lonial
Pageof 1